Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aradhana Rani

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Frontiers in Endocrinology|May 20, 2024
RAR-related orphan receptor alpha and the staggerer mice: a fine molecular storyAradhana Rani
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 31, 2015
STAT5 in Cancer and ImmunityAradhana Rani, John J Murphy
The American Journal of Pathology|August 18, 2019
Prostate Cancer: The Role of Inflammation and ChemokinesAradhana Rani, Prokar Dasgupta, John J Murphy
Frontiers in Endocrinology|June 11, 2019
Endocrine Resistance in Hormone Receptor Positive Breast Cancer-From Mechanism to TherapyAradhana Rani, Justin Stebbing, Georgios Giamas, et al.
Cytokine & Growth Factor Reviews|April 13, 2016
HES1 in immunity and cancerAradhana Rani, Roseanna Greenlaw, Richard A Smith, et al.
Plos One|March 4, 2014
FRA2 is a STAT5 target gene regulated by IL-2 in human CD4 T cellsAradhana Rani, Roseanna Greenlaw, Manohursingh Runglall, et al.
Breast Cancer Research : BCR|November 1, 2014
Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor-positive breast cancersRicardo Ribas, Zara Ghazoui, Qiong Gao, et al.
Frontiers in Immunology|February 4, 2021
IL-15 Upregulates Telomerase Expression and Potently Increases Proliferative Capacity of NK, NKT-Like, and CD8 T CellsFiona Watkinson, Sandeep Krishan Nayar, Aradhana Rani, et al.
Journal of Clinical Pharmacology|July 14, 2016
PRT062607 Achieves Complete Inhibition of the Spleen Tyrosine Kinase at Tolerated Exposures Following Oral Dosing in Healthy VolunteersGreg Coffey, Aradhana Rani, Andreas Betz, et al.
Molecular Cancer Therapeutics|June 28, 2015
AKT Antagonist AZD5363 Influences Estrogen Receptor Function in Endocrine-Resistant Breast Cancer and Synergizes with Fulvestrant (ICI182780) In VivoRicardo Ribas, Sunil Pancholi, Stephanie K Guest, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Frontiers in Endocrinology|May 20, 2024
RAR-related orphan receptor alpha and the staggerer mice: a fine molecular storyAradhana Rani
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 31, 2015
STAT5 in Cancer and ImmunityAradhana Rani, John J Murphy
The American Journal of Pathology|August 18, 2019
Prostate Cancer: The Role of Inflammation and ChemokinesAradhana Rani, Prokar Dasgupta, John J Murphy
Frontiers in Endocrinology|June 11, 2019
Endocrine Resistance in Hormone Receptor Positive Breast Cancer-From Mechanism to TherapyAradhana Rani, Justin Stebbing, Georgios Giamas, et al.
Cytokine & Growth Factor Reviews|April 13, 2016
HES1 in immunity and cancerAradhana Rani, Roseanna Greenlaw, Richard A Smith, et al.
Plos One|March 4, 2014
FRA2 is a STAT5 target gene regulated by IL-2 in human CD4 T cellsAradhana Rani, Roseanna Greenlaw, Manohursingh Runglall, et al.
Breast Cancer Research : BCR|November 1, 2014
Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor-positive breast cancersRicardo Ribas, Zara Ghazoui, Qiong Gao, et al.
Frontiers in Immunology|February 4, 2021
IL-15 Upregulates Telomerase Expression and Potently Increases Proliferative Capacity of NK, NKT-Like, and CD8 T CellsFiona Watkinson, Sandeep Krishan Nayar, Aradhana Rani, et al.
Journal of Clinical Pharmacology|July 14, 2016
PRT062607 Achieves Complete Inhibition of the Spleen Tyrosine Kinase at Tolerated Exposures Following Oral Dosing in Healthy VolunteersGreg Coffey, Aradhana Rani, Andreas Betz, et al.
Molecular Cancer Therapeutics|June 28, 2015
AKT Antagonist AZD5363 Influences Estrogen Receptor Function in Endocrine-Resistant Breast Cancer and Synergizes with Fulvestrant (ICI182780) In VivoRicardo Ribas, Sunil Pancholi, Stephanie K Guest, et al.
Pageof 2